Annexon, Inc. (ANNX) vs Design Therapeutics, Inc. (DSGN)
- Annexon, Inc. ANNX 3.41 −5.28%
- Design Therapeutics, Inc. DSGN 10.31 −1.62%
Annexon, Inc. and Design Therapeutics, Inc. are both Biotechnology companies. Annexon, Inc. and Design Therapeutics, Inc. are of similar size ($682.5M and $655.9M). Across the 8 metrics below, Design Therapeutics, Inc. leads on 6 and Annexon, Inc. on 2.
Valuation
Profitability
| Metric | ANNX | DSGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (105.26%) | (34.13%) | (56.36%) |
| Return on assets | (79.38%) | (32.33%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack